Cannabidiol, or CBD for short, may be one of the most talked about, yet misunderstood, players in the cannabis industry. As one of over 100 naturally occurring compounds found in cannabis that belong to a class of ingredients called cannabinoids, research points to CBD having therapeutic properties and lasting benefits across a broad range of health conditions.
Not to be confused with Tetrahydrocannabinol (THC), the psychoactive component of cannabis that produces mind-altering effects to give users a feeling of euphoria or being “high,” CBD is non-intoxicating and can provide relief and benefits without the disconcerting sense of lethargy or feeling depressed.
Cannabis is the most BIO-IDENTICAL plant to the human endo-cannabinoid system there is.
CBD, CBN and THC fit like a lock and key into existing receptors. These receptors are part of the endo-cannabinoid system which impacts physiological processes affecting pain modulation, and appetite plus anti-inflammatory effects and other immune system responses. The endocannabinoid system comprises two types of receptors CB1 and CB2, which serve distinct functions in animal health and well- being.
PHYTO-CANNABINOIDS are used to supplement depleted endo-cannabinoids in the body to bring the body back to homeostasis.
The cannabinoid receptors are G protein-coupled receptors that are activated by endocannabinoids or exogenous agonists such as tetrahydrocannabinol. CBD does not directly fit CB1 or CB2 receptors but has powerful indirect effects still being studied.
With CBD market growth and new products hitting mainstream markets online and in stores, it is important to know that not all cannabis products are made equal. Many new products are made from isolated cannabinoids, not full plant extracts also called whole plant.
CBD is a powerful component found to help reduce and lessen the impact of inflammation on oxidative stress. Inflammation controls our lives. It is key to conditions like rheumatoid arthritis, type 1 and type 2 diabetes, heart disease, atherosclerosis, chronic pain, metabolic syndrome, Alzheimer’s disease, depression, cancer, and more. Inflammation is also a leading cause of disease and death. Minimizing inflammation is vital to improving health and longevity. Tumor necrosis factor (TNF) is a major inducer of inflammation and TNF levels correspond to inflammation levels in the body. Increased TNF means more inflammation. CBD has shown to reverse this process by shrinking tumor or cancer cells.
A survey conducted by the Brightfield Group and HelloMD, which happens to be the largest survey on CBD usage to date, found that out of the 2,400 people participating, the most common reasons people used CBD were to reduce insomnia, depression, anxiety and joint pain. Interestingly, 42% of the participants using CBD reported they had stopped using traditional medications like pain relievers and prescription drugs, replacing those drugs with premium-quality CBD.
Through decades of preclinical laboratory work, research points to CBD having useful properties, including:
Bioavailability refers to the degree to which an active ingredient becomes available for its desired purpose after entering the body. In this case, it refers to the ability of CBD to enter the bloodstream after being taken orally. Regular CBD bioavailability is inherently low when administered orally as it must pass through the digestive system before reaching the bloodstream. Generally, as much as 90% of regular CBD is destroyed in the gastrointestinal tract before it is able to reach its intended receptors. Ultradiol uses a groundbreaking proprietary nanotechnology to yield superior bioavailability – a nearly 20x increase from regular CBD. The significant amplification of our product's bioavailability through the use of this technology allows for consistent results using a delivery method that is overwhelmingly preferred by consumers.